DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
17.15
-1.67 (-8.85%)
Feb 27, 2025, 3:56 PM EST - Market closed
DENTSPLY SIRONA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 3,793 | 3,965 | 3,922 | 4,231 | 3,339 | Upgrade
|
| Revenue Growth (YoY) | -4.34% | 1.10% | -7.30% | 26.71% | -16.98% | Upgrade
|
| Cost of Revenue | 1,835 | 1,875 | 1,795 | 1,887 | 1,639 | Upgrade
|
| Gross Profit | 1,958 | 2,090 | 2,127 | 2,344 | 1,700 | Upgrade
|
| Selling, General & Admin | 1,605 | 1,617 | 1,596 | 1,547 | 1,309 | Upgrade
|
| Research & Development | 165 | 184 | 174 | 171 | 123 | Upgrade
|
| Operating Expenses | 1,770 | 1,801 | 1,770 | 1,718 | 1,432 | Upgrade
|
| Operating Income | 188 | 289 | 357 | 626 | 268 | Upgrade
|
| Interest Expense | -69 | -97 | -76 | -64 | -46 | Upgrade
|
| Interest & Investment Income | - | 16 | 11 | 3 | - | Upgrade
|
| Earnings From Equity Investments | - | -4 | -36 | 32 | -1 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 3 | -6 | 9 | 13 | Upgrade
|
| Other Non Operating Income (Expenses) | 12 | -1 | -1 | -36 | -4 | Upgrade
|
| EBT Excluding Unusual Items | 131 | 206 | 249 | 570 | 230 | Upgrade
|
| Merger & Restructuring Charges | -53 | -74 | -14 | -28 | - | Upgrade
|
| Impairment of Goodwill | -1,014 | -291 | -1,187 | - | -157 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -3 | 3 | - | Upgrade
|
| Asset Writedown | - | -16 | -100 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -123 | Upgrade
|
| Pretax Income | -936 | -175 | -1,055 | 545 | -50 | Upgrade
|
| Income Tax Expense | -26 | -43 | -105 | 134 | 23 | Upgrade
|
| Earnings From Continuing Operations | -910 | -132 | -950 | 411 | -73 | Upgrade
|
| Net Income | -910 | -132 | -950 | 411 | -73 | Upgrade
|
| Net Income to Common | -910 | -132 | -950 | 411 | -73 | Upgrade
|
| Shares Outstanding (Basic) | 203 | 212 | 216 | 218 | 219 | Upgrade
|
| Shares Outstanding (Diluted) | 203 | 212 | 216 | 220 | 219 | Upgrade
|
| Shares Change (YoY) | -4.15% | -1.62% | -2.13% | 0.46% | -2.32% | Upgrade
|
| EPS (Basic) | -4.48 | -0.62 | -4.41 | 1.88 | -0.33 | Upgrade
|
| EPS (Diluted) | -4.48 | -0.62 | -4.41 | 1.87 | -0.33 | Upgrade
|
| Free Cash Flow | 281 | 228 | 368 | 515 | 562 | Upgrade
|
| Free Cash Flow Per Share | 1.38 | 1.08 | 1.71 | 2.34 | 2.56 | Upgrade
|
| Dividend Per Share | - | 0.560 | 0.500 | 0.430 | 0.400 | Upgrade
|
| Dividend Growth | - | 12.00% | 16.28% | 7.50% | 5.26% | Upgrade
|
| Gross Margin | 51.62% | 52.71% | 54.23% | 55.40% | 50.91% | Upgrade
|
| Operating Margin | 4.96% | 7.29% | 9.10% | 14.80% | 8.03% | Upgrade
|
| Profit Margin | -23.99% | -3.33% | -24.22% | 9.71% | -2.19% | Upgrade
|
| Free Cash Flow Margin | 7.41% | 5.75% | 9.38% | 12.17% | 16.83% | Upgrade
|
| EBITDA | 537 | 632 | 685 | 972 | 588 | Upgrade
|
| EBITDA Margin | 14.16% | 15.94% | 17.47% | 22.97% | 17.61% | Upgrade
|
| D&A For EBITDA | 349 | 343 | 328 | 346 | 320 | Upgrade
|
| EBIT | 188 | 289 | 357 | 626 | 268 | Upgrade
|
| EBIT Margin | 4.96% | 7.29% | 9.10% | 14.80% | 8.03% | Upgrade
|
| Effective Tax Rate | - | - | - | 24.59% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.